SHANGHAI, June 25, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the National Medical Products Administration (NMPA) of China has accepted the New Drug Application (NDA) for...
Hence then, the article about carsgen therapeutics announces nda acceptance of satri cel by china s nmpa was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( CARsgen Therapeutics Announces NDA Acceptance of Satri-cel by China's NMPA )
Also on site :
- Citizens Bank Customers Targeted in Third-Party Data Breach .. PYMNTS.com
- Exclusive: Omni raises $120 million to fix one of AI’s biggest enterprise data problems
- India to Iran: How two wars shaped the rise of Pakistan’s Asim Munir